Physician profile
Farah Sagheer
NPI 1295954410
$1,582.28
in general payments reported to CMS, 2019-2025
11 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.32 · 2022: $726 · 2023: $354 · 2024: $214 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $726.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $245.06 | 2023 | Zeposia |
| Glaxosmithkline, LLC. | $163.01 | 2025 | Trelegy Ellipta, Arexvy, Nucala |
| Phathom Pharmaceuticals, INC. | $130.00 | 2024 | Voquezna |
| Celgene Corporation | $62.22 | 2023-2024 | Zeposia |
| Ardelyx, INC. | $53.97 | 2025 | Ibsrela |
| Apria Healthcare LLC | $52.32 | 2021 | |
| 3b Medical, INC. | $48.08 | 2023-2024 | Luna |
| Abbvie INC. | $41.77 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $33.72 | 2023-2024 | Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.13 | 2023 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farah Sagheer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.